Stay updated on Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe revision label changed from v3.6.5 to v3.6.6, representing a new version in the site’s revision history. It does not reflect changes to the study details or user-visible information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedNew study documents with associated dates and file sizes are now linked in the Study Details page, along with updated verification timestamps from the sponsor team. This addition provides access to key consent and protocol materials and contextual metadata.SummaryDifference53%

- Check37 days agoChange DetectedThe page shows revision v3.6.5, replacing v3.6.4, indicating a new version of the page. It's a metadata update rather than a change to study content or functionality.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 on the page. This indicates a minor content/metadata update and does not change any study details.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision tag was updated to v3.6.3, replacing the previous version v3.6.2. This appears to be a minor maintenance update that does not modify the study content or patient-facing information.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision tag on the page was updated to v3.6.2, replacing the previous v3.6.0. This indicates an update to the study documents or protocol associated with the clinical trial record.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab After Non-ablative Radiation in NSCLC Clinical Trial page.